Integra LifeSciences Holdings Corporation
IART
$9.55
-$0.02-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -516.47M | -495.34M | -500.63M | -28.96M | -6.94M |
| Total Depreciation and Amortization | 151.83M | 158.09M | 155.53M | 147.52M | 140.89M |
| Total Amortization of Deferred Charges | 5.61M | 5.99M | 6.01M | 5.58M | 5.59M |
| Total Other Non-Cash Items | 443.16M | 450.94M | 461.25M | 10.54M | 20.85M |
| Change in Net Operating Assets | -33.74M | -30.38M | -51.28M | -32.31M | -31.01M |
| Cash from Operations | 50.38M | 89.31M | 70.89M | 102.37M | 129.38M |
| Capital Expenditure | -81.44M | -93.82M | -108.31M | -117.87M | -104.42M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 4.18M | 4.18M | -277.81M | -277.81M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.63M | 12.23M | 31.92M | 22.92M | -8.58M |
| Cash from Investing | -108.06M | -77.41M | -72.21M | -372.76M | -390.81M |
| Total Debt Issued | 720.70M | 706.40M | 124.50M | 170.40M | 486.50M |
| Total Debt Repaid | -669.89M | -684.75M | -112.62M | -187.28M | -187.13M |
| Issuance of Common Stock | 957.00K | 957.00K | 957.00K | 957.00K | 6.40M |
| Repurchase of Common Stock | -2.92M | -5.39M | -5.36M | -55.00M | -55.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.52M | -20.38M | -20.31M | -14.52M | -11.92M |
| Cash from Financing | 28.34M | -3.16M | -12.83M | -85.44M | 237.86M |
| Foreign Exchange rate Adjustments | 18.02M | 8.28M | 16.83M | 3.03M | -6.46M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.33M | 17.03M | 2.68M | -352.80M | -30.03M |